Absorption |
Blood-Brain Barrier | BBB+ | 0.9620 |
Human Intestinal Absorption | HIA+ | 1.0000 |
Caco-2 Permeability | Caco2+ | 0.8220 |
P-glycoprotein Substrate | Substrate | 0.6977 |
P-glycoprotein Inhibitor | Inhibitor | 0.5847 |
Non-inhibitor | 0.9067 |
Renal Organic Cation Transporter | Non-inhibitor | 0.7627 |
Distribution |
Subcellular localization | Mitochondria | 0.8602 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.8235 |
CYP450 2D6 Substrate | Non-substrate | 0.9341 |
CYP450 3A4 Substrate | Substrate | 0.7465 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.9620 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.9401 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.9480 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.8843 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.8680 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9155 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9146 |
Non-inhibitor | 0.7774 |
AMES Toxicity | Non AMES toxic | 0.9167 |
Carcinogens | Non-carcinogens | 0.9553 |
Fish Toxicity | High FHMT | 0.9928 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.9361 |
Honey Bee Toxicity | High HBT | 0.8174 |
Biodegradation | Not ready biodegradable | 0.9522 |
Acute Oral Toxicity | III | 0.4405 |
Carcinogenicity (Three-class) | Warning | 0.4546 |